comprehensive -WSS

comprehensive

author：explore 2025-10-01 23:31:17 - browse：89746

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： See how much Covid

explore

WSS

ASCO: AstraZeneca says CAR

RaDonda Vaught to speak at CommonSpirit event on patient safety

Pfizer highlights cancer drugs it thinks could reignite investor interest

Obesity now affects over 1 billion people worldwide, study finds

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

FDA's Pazdur wants cancer trials to range beyond China alone

Wikipedia

comprehensive

hotspot

Affirmative action in medical school literally saved lives

Why getting cancer drugs just got harder for rural patients

Dobbs anniversary: the lost opportunity of abortion as health care

Shifting the focus from loneliness to social health

Walensky prepares to leave CDC — and Congress — behind

How to fix the rural physician shortage in the U.S.

Cancer drug shortages should be causing more outrage

See how much Covid

New air purifier tech could be key to improving indoor air quality

Flu vaccine offering decent levels of protection this winter, new data show

hotspot

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

HIV drugs protect against transmission, even in unprotected sex

ALS groups 'won't be played again' by the FDA, drug sponsors

Change Healthcare can notify patients about the breach, HHS says

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

At ASCO, AstraZeneca reports strong data for breast cancer drug

hotspot

leisure time

explore

knowledge